References
-
1
Feinberg B, Kurzrock R, Talpaz M. et al .
A Phase I clinical trial of intravenously administered recombinant tumor necrosis alpha in cancer patients.
J Clin Oncol.
1988;
6
1328-1334
-
2 Orth D N, Kovacs W J. 1998 The adrenal cortex. In: Williams textbook of Endocrinology, 9th Edition. Wilson JD, Foster DW, Kronenberg HM, Larsen PR, eds. Philadelphia; Saunders Publishing Co, Chap. 12
-
3
van Praag H M.
Faulty cortisol/serotonin interplay.
Psychiatry Res.
1996;
65
143-157
-
4
Snyder S H.
Serotonin sustains serenity.
Nature.
2002;
416
377-380
-
5 McCann S M, Karanath S, Kamat A. et al .1995 Role of cytokines in hypothalamic-pituitary functions. In: Human cytokines, their role in disease and therapy. Aggarwal BB, Puri RK, eds Blackwell Press, Chap. 18
-
6
Fukuda K.
The chronic fatigue syndrome: a comprehensive approach to its definition and study. International chronic fatigue study group.
Ann Intern Med.
1994;
121
953-959
-
7
Landay A L, Jessop C, Lennette E T, Levy J A.
Chronic fatigue syndrome: clinical condition associated with immune activation.
Lancet.
1991;
338
707-712
-
8
Demitrack M A, Dale J K, Strauss S E. et al .
Evidence for impaired activation of the hypothalamic-pituitary-adrenal axis in patients with chronic fatigue syndrome.
J Clin Endocrinol Metab.
1991;
73
1224-1234
-
9
Komaroff A L.
The biology of chronic fatigue syndrome.
Am J Med.
2000;
108
169-171
-
10
Cleare A J, Heap E, Malhi G. et al .
Low-dose hydrocortisone in chronic fatigue syndrome; a randomised crossover trial.
Lancet.
1999;
353
455-458
-
11
Caruso I, Sarzi-Puttini P, Cazzola M, Azzolini V.
Double-blind study of 5-hydroxytyptophan versus placebo in the treatment of primary fibromyalgia syndrome.
J Internat Med Res.
1990;
18
201-209
M. J. Renan, Ph. D.
Division of Medical Microbiology · Health Sciences Faculty · University of Cape Town · Observatory
Cape Town 7925 · South Africa ·
Telefon: +21 (406) 63 63
Fax: +21 (448) 81 53
eMail: mrenan@curie.uct.ac.za
